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Amphotericin, miconazole, and ciclopirox are anti-
fungal agents from three different drug classes that
can effectively kill planktonic yeast, yet their com-
plete fungicidal mechanisms are not fully under-
stood. Here, we employ a systems biology approach
to identify a common oxidative-damage cellular
death pathway triggered by these representative
fungicides in Candida albicans and Saccharomyces
cerevisiae. This mechanism utilizes a signaling cas-
cade involving the GTPases Ras1 and Ras2 and
protein kinase A, and it culminates in death through
the production of toxic reactive oxygen species in
a tricarboxylic-acid-cycle- and respiratory-chain-
dependent manner. We also show that the metabo-
lome of C. albicans is altered by antifungal drug
treatment, exhibiting a shift from fermentation to
respiration, a jump in the AMP/ATP ratio, and ele-
vated production of sugars; this coincides with ele-
vated mitochondrial activity. Lastly, we demonstrate
that DNA damage plays a critical role in antifungal-
induced cellular death and that blocking DNA-repair
mechanisms potentiates fungicidal activity.INTRODUCTION
A rapid rise in immunocompromised patients over the past five
decades has led to increasing incidence of systemic fungal infec-
tions. Despite current treatment options, the morbidity and mor-
tality rates associated with fungal infections, particularly those of
Candida species, remain high (Ostrosky-Zeichner et al., 2010).
The polyene amphotericin B (AMB), introduced in the late
1950s, was the first widely used antifungal (AF) drug (Ostrosky-
Zeichner et al., 2010). Due to its strong hydrophobicity, AMB
penetrates the fungal membrane and binds to ergosterol, leading
to membrane damage. Azoles, a second class of AFs, became
available in the 1980s and act by inhibiting ergosterol biosyn-
thesis to induce the accumulation of a toxic methylated sterol
that stops cell growth (Ostrosky-Zeichner et al., 2010). Although350 Cell Reports 3, 350–358, February 21, 2013 ª2013 The Authorsazoles tend to be fungistatic, some azoles such as miconazole
(MCZ) can be fungicidal under certain conditions and formula-
tions (Thevissen et al., 2007). Unlike AMB and MCZ, the primary
targets of the synthetic AF ciclopirox olamine (CIC) are not fully
understood, though some evidence indicates that CIC acts by
affecting DNA repair or directly inducing DNA damage (Leem
et al., 2003).
Recent work with select AFs has indicated that AF-induced
cellular death may follow apoptotic or necrotic pathways that
involve the production of reactive oxygen species (ROS) (Phillips
et al., 2003; Thevissen et al., 2007) and the modulation of central
metabolism (Gonza´lez-Pa´rraga et al., 2011; Yan et al., 2007).
However, a comprehensive genetic and metabolic mechanism
of AF-induced cellular death remains elusive.
Recent systemsbiologywork fromour lab, focusedonbacterial
cell death, identified a common mechanism of antibiotic action
that involves a genetic and metabolic cascade that ultimately
results in the formation of toxicROS (Dwyer et al., 2007; Kohanski
et al., 2007, 2008). Aspects of this mechanism have been har-
nessed to potentiate currently available antibiotics and combat
the development of resistance (Dwyer et al., 2009; Kohanski
et al., 2007, 2010; Lu and Collins, 2009). Similar approaches to
AF mechanisms could provide important, meaningful insights
and identify possible means to improve current treatments.
In this work, we apply a systems biology approach to identify
mechanisms by which the aforementioned AFs—AMB, MCZ,
and CIC—lead to fungal cellular death. We find that, despite their
different primary modes of action, all three classes of fungicidal
drugs induce a common oxidative-damage cellular death path-
way in Saccharomyces cerevisiae and Candida albicans that
involves alterations to cellularmetabolism and respiration, culmi-
nating in the formation of lethal ROS.RESULTS
Fungicide-Dependent ROS Production Leads to Fungal
Cell Death
Based on previous work that supports the cidal role of ROS
production in many modes of fungal death (Breitenbach et al.,
2005; Henriquez et al., 2008), we hypothesized that ROSproduc-
tion is critical to AF-induced cellular death. We measured the
formation of ROS following AF treatment in yeast using the dye
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Figure 1. Fungicide-Dependent ROS Production Leads to Fungal Cell Death and a Common Transcriptional Response
(A and B) Generation of ROS as measured by a change in HPF fluorescence after 1.5 hr of drug treatment in S. cerevisiae (A) and C. albicans (B).
(C) Log of CFU/ml remaining after drug exposure in the presence and absence of 50 mM thiourea (TU). Drug concentrations used: AMB 1 mg/ml, MCZ 50 mg/ml,
CIC 75 mg/ml, H2O2 1 mM, geneticin (G418) 100 mg/ml, fluconazole (FLC) 50 mg/ml, 5-flucytosine (5-FC) 15 mg/ml, and ketoconazole (KTZ) 50 mg/ml. The reported
error is SD with nR 3.
(D) A common transcriptional response to AF treatment was identified by performing differential expression analysis against a compendium of expression arrays.
The common set of differentially expressed genes is represented by the intersection of the three sets of genes.
(E) Pathway analysis of the common set of differentially expressed genes identified six major processes that are upregulated in response to AFs and three
processes that are downregulated under the same treatments.
See also Figure S1 and Table S1.30-(p-hydroxyphenyl) fluorescein (HPF), which is preferentially
oxidized by intracellular hydroxyl radicals into a fluorescent
product (Kohanski et al., 2007). We treated exponentially
growing wild-type S. cerevisiae and C. albicans in synthetic
dextrose complete (SDC) medium with the minimum concentra-
tion of fungicide required to achieve at least a 90% reduction in
colony-forming units (CFU) after 3 hr of exposure. As a positiveCcontrol, we also treated cells with H2O2, a potent inducer of
hydroxyl radical formation (Perrone et al., 2008). After 1.5 hr of
treatment, we found that all tested fungicidal drugs and H2O2
lead to dramatic induction of HPF fluorescence (Figure 1A, 1B,
and S1), indicating that all tested fungicidal agents induce the
formation of ROS. Conversely, fungistatic drugs added at con-
centrations 10-fold above the minimal inhibitory concentrationell Reports 3, 350–358, February 21, 2013 ª2013 The Authors 351
or at the maximum soluble concentration did not lead to detect-
able ROS formation (Figures 1A, 1B, and S1).
To test whether the observed production of ROS contributes
to AF-induced cellular death, we treated cells with thiourea, a
potent scavenger of hydroxyl radicals in eukaryotic and prokary-
otic cells (Kohanski et al., 2007; Touati et al., 1995).We found that
exposing exponentially growing S. cerevisiae to 50 mM thiourea
for 30 min prior to the addition of AF drugs considerably dimin-
ished the toxicity of all three AFs, reducing killing at 3 hr by
15-fold for AMB and CIC and by 10-fold for MCZ (Figure 1C).
These results indicate that ROS production plays a critical role in
cellular death following treatment by AMB, MCZ, and CIC.
Identifying a Common Transcriptional Response to AF
Treatment
To build a comprehensive model of the yeast response to
AFs, we measured changes in global gene expression of
S. cerevisiae following treatment with AMB, MCZ, and CIC. To
assess the effect of each AF treatment on gene expression, we
performed a z-test between experiment and control samples,
where the average and SD for the expression of each gene
was calculated across a compendium of publically available
expression data sets (see Extended Experimental Procedures).
We compared the differential gene-expression profile of each
treatment at each time point to the no-treatment control to iden-
tify the set of genes commonly perturbed by fungicide treatment
(Figure 1D). This analysis revealed that 43 genes were commonly
upregulated under AF treatment, while 79 genes were downre-
gulated under the same conditions (Figure 1E). To investigate
the biological pathways and processes in which these genes
are involved, we ran a functional enrichment analysis on Gene
Ontology (GO) terms associated with each one of these genes.
The analysis was conducted with the Saccharomyces Genome
Database’s GO Term Finder tool using default parameters. The
majority of the commonly downregulated genes are involved in
protein synthesis, specifically, ribosomal biogenesis and tRNA
synthesis. The 43 commonly upregulated genes fall into six
general biological processes: the production of storage sugars,
endocytosis, general stress response, osmolarity maintenance,
central carbon metabolism, and the RAS/protein kinase A
(PKA) signaling pathway (Figure 1E).
Our expression analysis identified the production of storage
sugars as a key process upregulated following AF treatment.
Specifically, genes involved in glycogen metabolism and the
production of the storage sugar trehalose were robustly upregu-
lated after the addition of fungicides (Figure 1E; Table S1).
Cellular production of trehalose and glycogen are energy-expen-
sive pathways that consume significant amounts of ATP. Consis-
tent with this, the activation of the trehalose pathway has been
shown to increase ATP consumption, mitochondrial enzyme
content, and respiration (Noubhani et al., 2009). Thus, the
production of these sugars may contribute to increased mito-
chondrial activity and elevated ROS production.
TCA Cycle and Electron Transport Chain Play Critical
Roles in AF-Induced Cell Death
To identify genes critical to AF action, we tested the AF sensitivity
of single-gene knockouts identified through our common tran-352 Cell Reports 3, 350–358, February 21, 2013 ª2013 The Authorsscriptional analysis. In total, we tested the AF sensitivities of 81
single-gene knockouts (Table S2) and found that 12 of them
had increased resistance to all three AFs (AMB, MCZ, CIC).
Actively respiring, energy-producing mitochondria are the
major source of ROS in yeast cells. However, S. cerevisiae respi-
ratory activity is usually repressed under normal growth condi-
tions in the presence of glucose (Hardie et al., 1999), though
various stress responses have been shown to upregulate
respiratory genes even in the presence of glucose (Gasch
et al., 2000). We therefore hypothesized that treatment with
fungicides induces a switch from normal fermentative growth
to mitochondrial respiration.
To assess the role of mitochondrial respiration in AF-induced
cellular death, we first analyzed the expression of mitochondrial
genes in S. cerevisiae in response to AF treatment (Table S1). Of
particular interest, we found that the gene encoding the rate-
limiting step of the tricarboxylic acid (TCA) cycle, citrate syn-
thase-1 (CIT1), exhibited a slight increase in expression across
all AF treatments. The induction of CIT1 is a hallmark of stress-
induced respiration (Gasch et al., 2000). We found that deleting
CIT1, CIT2, or CIT3 dramatically reduced yeast sensitivity to all
three AFs when compared to the wild-type S. cerevisiae strain
(Figures 2A and S2). To parse out the role of the various citrate
syntheses in AF-induced cellular death, we created single and
double deletions of CIT1 and CIT2 in the cit3 background. We
found that deleting the remaining citrate synthases in this back-
ground provides additive resistance to AMB, with the triple
mutant requiring more than 8-fold-higher drug concentrations
to achieve the sensitivity of the singlemutants (Figures 2C). Inter-
estingly, a similar additive effect was not observed with MCZ or
CIC, indicating that AMB toxicity is more sensitive to further
changes in citrate metabolism than the other two drugs.
We also found that deleting succinate dehydrogenases (SDH1
or SDH2), enzymes that couple the oxidation of succinate to the
transfer of electrons to themitochondrial electron transport chain
(ETC) (Chapmanetal., 1992), decreaseddrugsusceptibility.Addi-
tionally, we found that disrupting the TCA cycle at these two
key points reduces the AF-dependent production of ROS (Fig-
ure 2B), indicating that this phenomenon involves the TCA cycle.
The TCA cycle produces NADH, which is then fed into the ETC
to produce ATP. This activity also leads to the production of ROS
as a byproduct of aerobic respiration. We therefore targeted the
first committed steps of the ETC by deleting the intramitochon-
drial NADH dehydrogenase (NDI1) and the external NADH dehy-
drogenase (NDE1). The NDI1 and NDE1 deletions exhibited
increased resistance to all three AF drugs and a concomitant
reduction in AF-dependent ROS production (Figures 2A and 2B).
We next sought to assess the mitochondrial activity of AF-
treated fungal cells. We utilized the MitoTracker Red dye, which
enters the mitochondrial matrix by utilizing the proton motive
force and thus labels metabolically active mitochondria in viable
cells (Arita et al., 2006; Tomas et al., 2011). We incubated expo-
nential phase S. cerevisiae in glucose-free synthetic complete
(SC) media for 30 min and then switched them to SC containing
2% glucose or nonfermentable acetate for 1.5 hr. As expected,
we detected approximately 5-fold more MitoTracker fluores-
cence in acetate-incubated cells (Figure 2D), indicating that the
dye specifically labels cells with activated mitochondria. Adding
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Figure 2. TCA-Dependent Respiration and
the Ras/PKA Pathway Play a Critical Role
in AF-Induced Cell Death
(A and E) Log of CFU/ml remaining after 3 hr of
drug exposure of wild-type S. cerevisiae and
mutants targeting the TCA cycle, respiration, and
the Ras/PKA pathway.
(B and F) Cellular ROS levels quantified as percent
change in fluorescence after the addition of HPF.
The indicated strains were treated with AF
drugs for 1 hr prior to the addition of HPF. Drug
concentrations used: AMB 1 mg/ml, MCZ 50 mg/ml,
and CIC 75 mg/ml.
(C) Log of CFU/ml remaining after 3 hr of drug
exposure. Drug concentrations used, increasing
from left to right: AMB (1 mg/ml, 1.5 mg/ml,
2.5 mg/ml, and 8 mg/ml), MCZ (50 mg/ml,
75 mg/ml, 100 mg/ml, and 150 mg/ml), and CIC
(75 mg/ml, 100 mg/ml, 125 mg/ml, and 150 mg/ml).
The reported error is SD with nR 3.
(D) Yeast mitochondrial content assayed by
fluorescent staining with MitoTracker Red probe
after 1 hr of exposure to the indicated drug or
metabolite.
See also Figure S2 and Table S2.CIC, AMB, or MCZ to glucose-incubated cells increased Mito-
Tracker fluorescence by 10-fold, 60-fold, and 70-fold, respec-
tively (Figure 2D). All three drugs induced considerably more
mitochondrial activity than acetate, indicating that AF treatment
has a greater impact on mitochondrial activity than normal respi-
ratory metabolism. These results are consistent with our hypoth-
esis that AF drugs induce a shift from fermentative growth to
ROS-producing mitochondrial respiration.
RAS/PKA Pathway Is a Key Mediator of AF Toxicity
Having established that AFs induce mitochondrial-dependent
ROSproduction,wenext sought to ascertain the signaling events
that lead to these metabolic changes. The RAS/PKA pathway,
consisting of two GTPases (Ras1 and 2) and three PKA isoforms
(Tpk1-3), has been shown to respond to cellular stress by in-
ducing mitochondrial biogenesis and cellular death through the
production of ROS via disordered mitochondrial respiration
(Chevtzoff et al., 2010; Leadsham and Gourlay, 2010; Thevelein
and de Winde, 1999). We found that aspects of this signaling
pathway were upregulated in response to AFs (Table S1). ForCell Reports 3, 350–358,example, TPK1 and TPK2 were robustly
induced in response to AF treatment,
and we found an increase in expression
of other genes involved in the same
pathway (Table S1), namely, BMH2,
CYR1, and SRV2. Further, we found that
PDE2, the cyclic AMPphosphodiesterase
that represses the RAS/PKA signaling,
was significantly downregulated. Deleting
PDE2 in the presence of activated RAS/
PKA signaling has been shown to lead to
the overproduction of ROS by dysfunc-
tional mitochondria, resulting in cellulardeath (Leadsham and Gourlay, 2010). Together, these results
indicate that the RAS/PKA signaling pathway is largely upregu-
lated in response to AF treatment and may contribute to the
production of ROS by mitochondria.
We tested the role of the RAS/PKA pathway in AF-induced
cellular death by studying single-gene knockouts of the up-
stream and downstream portions of the pathway. We found
that deleting either RAS1 or RAS2 reduced yeast susceptibility
to all three AFs (Figures 2E and S2) and deleting the downstream
effector kinases, TPK1, TPK2 and TPK3, also reduced or de-
layed killing. Additionally we found that deleting any one of the
key members of the RAS/PKA signaling pathway reduced the
drug-dependent buildup of ROS (Figure 2F). This finding sug-
gests that RAS/PKA signaling is critical for the induction of mito-
chondrial ROS production in response to drug treatment.
Common Metabolic Changes Resulting from AF
Treatment
Our results link AF treatment to distinct changes in intracellu-
lar metabolic activity as part of an induced common killingFebruary 21, 2013 ª2013 The Authors 353
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Figure 3. AF Treatment Leads to Common
Metabolic ChangesResulting in the Produc-
tion of Sugars and a Dramatic Reduction of
ATP Levels
(A) A schematic of the metabolomics study.
Cells were treated with AF drugs for 1.5 hr and
intracellular metabolites were analyzed using
mass spectrometry to identify the AF-perturbed
metabolome.
(B) Fold change in metabolite levels compared to
the no-treatment control.
(C and D) Relative signal intensity of select
metabolites identified through metabolomic pro-
filing of C. albicans exposed to AF drugs for 1.5 hr.
Drug concentrations used: AMB 1 mg/ml, MCZ
50 mg/ml, and CIC 75 mg/ml. The reported error is
SEM with n = 6.
(E) AMP/ATP ratio inC. albicans treated with drugs
over a 90 min period. Drug concentrations used:
AMB 0.35 mg/ml, MCZ 50 mg/ml, andCIC 75 mg/ml.
The reported error is SD with an nR 3.
See also Figures S3 and S4.mechanism. To further explore the role of metabolism in AF-
induced cellular death, we directly measured the effect of AF
treatment on the intracellular metabolome of C. albicans. To
do so, we utilized a platform for metabolite detection and relative
quantification from Metabolon (Durham, NC, USA) (Evans et al.,
2009). We treated exponentially growing C. albicans cells with
AFs and collected samples for metabolomic analysis after
1.5 hr of treatment, a time point when we expected at least
90% of cells contributing to the metabolite pool to be irreversibly
committed to the death pathway (Figure S3). We found that
the three drug treatments (AMB, MCZ, and CIC) significantly
changed (p % 0.05) the relative abundance of between 155
and 213 metabolites when compared to the no-treatment
controls (Data Set S1).
Glucose was the most highly induced metabolite, found to be
greater than 600-fold more abundant in drug-treated cells (Fig-
ure 3B). Other carbohydrates, such as fructose and mannose,
were also significantly more abundant in all of the treatment
groups compared to the control, as was the disaccharide treha-
lose (Figure 3B). These results are consistent with our microarray
data that identified the upregulation of polysaccharide biosyn-
thesis as an important transcriptional response to AF treatment.
Our phenotypic analyses in S. cerevisiae suggested that cells
may be switching from exclusively fermentative growth to mito-
chondrial respiration in response to AF treatment. Consistent
with this result, we found that 2,3-butanediol and glycerol,
two major fermentative waste products (Gonza´lez et al., 2000),354 Cell Reports 3, 350–358, February 21, 2013 ª2013 The Authorswere substantially reduced after AF treat-
ment (Figure 3C). Furthermore, pyruvate
levels were dramatically lower in drug-
treated samples (Figure 3D), indicating
possible consumption by the TCA cycle;
of note, TCA cycle intermediates were
also reduced (Data Set S1) in comparison
to the untreated cells. These measure-
ments, combined with our genetic dataand measurements of mitochondrial activity and biogenesis,
provide support for a common fungicidal mechanism of action
that relies on reduced fermentation and induced ROS-producing
mitochondrial respiration.
The dramatic elevation of intracellular sugars and the shift
from fermentation to respiration suggests that the AF treatments
may be increasing ATP consumption. Abundant nucleotides
such as ATP are not accurately quantified using the metabolic
platform we selected for this study. We therefore sought to
measure ATP levels over time using high-performance liquid
chromatography (HPLC). We analyzed the AMP/ATP levels in
lysates collected from cells treated with the three AFs. We found
that the AF treatments elevated the AMP/ATP ratio by between
4- and 24-fold (Figure 3E), through a large drop in ATP levels
and a proportional rise in AMP levels. ATP levels are normally
static but can change dramatically under severe stress condi-
tions that induce necrosis (Henriquez et al., 2008; Oso´rio et al.,
2004). Our results suggest that fungicide-stimulated sugar pro-
duction induces a necrosis-like rapid consumption of ATP.
DNARepair Is a Critical Response to AF-Dependent ROS
Production
ROS damage multiple cellular targets, including membranes,
proteins, and DNA (Kohanski et al., 2007; Salmon et al., 2004).
Recent work indicates that DNA repair, specifically double-
strand break repair (DSBR), plays a critical role in C. albicans
resistance to oxidative damage (Legrand et al., 2007, 2008).
Wechose to analyze the role of DNA repair in AF-induced cellular
death by testing the susceptibility of C. albicans strains with
deletions of critical genes in nucleotide excision repair, mis-
match repair, and DSBR. We used AMB, MCZ, and CIC at a
range of concentrations and found that DSBR mutants were
particularly susceptible to all three AFs when compared to
wild-type (Figures 4A–4C). Specifically, we found that the
minimal fungicidal concentrations for the DSBR mutants,
rad50/rad50 and rad52/rad52, were reduced by as much as
10-fold compared to wild-type.
Next we utilized the TUNEL assay to quantify the relative abun-
dance of double-strand breaks in C. albicans cells treated with
AFs and H2O2. The TUNEL reagent fluorescently labels both
double- and single-strand DNA breaks (Ribeiro et al., 2006).
Treating cells with AFs and H2O2 elevated relative fluorescence
as measured by flow cytometry (Figure 4D), indicating a consid-
erable induction of DNA breaks.
We also assayed rad50 and rad52 knockouts in S. cerevisiae
to test whether the role of DNA damage in AF toxicity is consis-
tent with the results from C. albicans. We found that these
mutants were considerably more susceptible to H2O2 and
AFs than wild-type S. cerevisiae, although the differences were
smaller than those seen with C. albicans. Together, these data
provide support for the role of DNA damage as a factor contrib-
uting to a common mechanism of AF action and indicate that
targeting DNA-repair mechanisms could be an effective means
for potentiating fungicidal activity.
For additional details, please see Extended Results.
DISCUSSION
In this work, we utilized a systems biology approach to study
the response of fungal cells to AF treatment. We found that
despite divergent primary modes of action, fungicides from
three distinct classes induce a common signaling and meta-
bolic cascade that leads to ROS-dependent cellular death
(Figure 4I). We propose that cellular changes and damage initi-
ated through interaction with primary targets of AFs result in
activation of a stress-like response that includes signaling
through the RAS/PKA pathway. Through this and possibly other
pathways, cells activate mitochondrial activity and shift from
fermentation to respiration in response to AFs. This abrupt
induction of mitochondrial activity leads to the overproduction
of toxic ROS in a manner that depends on the TCA cycle and
ETC. Additionally, we found that AF treatment leads to a buildup
of monosaccharides and disaccharides, including glucose and
trehalose. Both the import and synthesis of these sugars are
energetically expensive, requiring the consumption of ATP
and the production of AMP. It is likely that these metabolic
changes lead to altered respiration and the overproduction of
ROS by dysfunctional mitochondria, ultimately resulting in cell
death (Figure 4I).
The common AF-dependent responses identified in this work
have similarities to many fungal stress-response mechanisms
(Gasch et al., 2000; Soufi et al., 2009), suggesting that AF agents
may function by overactivating these pathways to induce cellular
death. These similarities include a collapse of ATP levels (Oso´rio
et al., 2004), mitochondrial dysfunction that leads to the produc-Ction of ROS (Breitenbach et al., 2005), and a central role played
by the RAS/PKA pathway (Estruch, 2000). It is likely that AFs
cause cellular damage that mirrors the effects of osmotic,
heat, and alcohol stress, leading to the induction of stress-
related pathways. Interestingly, the same responses that protect
cells from mild environmental stress may in fact contribute to
AF-dependent cellular death. AF insult to fungal cells may be
sufficiently powerful such that the overactivation of these general
stress responses does not protect the cell, but instead plays
a net contributory role in cellular death through the consumption
of ATP and the production of ROS.
In addition to similarities with known fungal stress pathways,
the identified common mechanism of AF-induced fungal cellu-
lar death can also be compared to the previously identified
common mechanism of antibiotic-mediated bacterial cellular
death (Dwyer et al., 2007; Kohanski et al., 2007). Despite the
complex and multilayered eukaryotic mechanism, robust simi-
larities can be found between the two phenomena, indicating
possible evolutionary conservation. In both prokaryotes and
eukaryotes, cellular damage resulting from the primary drug-
target interaction activates key metabolic regulators, such as
RAS in yeast and ArcA in bacteria (Kohanski et al., 2008). These
universal regulators modulate central metabolism through the
induction of the TCA cycle and respiratory activity to produce
toxic ROS.
The endpoint of the common antimicrobial mechanisms in
both bacteria and yeast is cellular death through the production
of toxic ROS. In both prokaryotes and eukaryotes, ROS induces
double-strand DNA breaks (Dwyer et al., 2012; Foti et al., 2012)
and other forms of cellular damage that lead to cellular death and
are potentiated by blocking DNA repair. In yeast, we demon-
strated that by blocking DSBR we could reduce the minimal
fungicidal concentration of the tested AF drugs by as much as
10-fold. Similarly, deleting RecA, an Escherichia coli homolog
of the yeast RAD genes, substantially enhances bactericidal
antibiotic activity in bacteria (Kohanski et al., 2007). These find-
ings suggest that inhibitors of DNA repair mechanisms may be
robust potentiators of fungicides and bactericidal antibiotics.
The critical role of ROS in antimicrobial activity indicates that
ROS generation may have evolved and been maintained in
both prokaryotes and eukaryotes as a central mechanism to
overcome environmental stress. Under various stress condi-
tions, low-level ROS production can activate multiple pro-
tective responses including the upregulation of antioxidant
enzymes and the induction of beneficial mutations (Belenky
and Collins, 2011; Gems and Partridge, 2008; Kohanski et al.,
2010). However, if ROS production goes above a certain
threshold, it no longer serves a protective role and instead
induces cellular death. Thus, it is likely that many lethal chal-
lenges, including fungicides, function by highjacking natural
stress-response mechanisms to induce ROS production above
this threshold.EXPERIMENTAL PROCEDURES
Fungal Strains and Media
S. cerevisiae strains used in this work were derivatives of BY4742, created as
part of the Deletion Consortium (Winzeler et al., 1999). Deletion Consortiumell Reports 3, 350–358, February 21, 2013 ª2013 The Authors 355
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Figure 4. DNA Repair Is a Critical Response to AF-Dependent ROS Production
(A–C) Log of CFU/ml remaining after 3 hr of drug exposure of wild-type C. albicans and mutants targeting DSBR (rad50/rad50 and rad52/rad52), nucleotide
excision (NER [rad10/rad10]), and mismatch (MMR [msh1/msh1]) DNA-repair mechanisms.
(D) TUNEL staining of exponentially growing cells assayed by flow cytometry after 2 hr of treatment. Drug concentrations used, decreasing from left to right: H2O2
(10 mM and 5 mM), AMB (1 mg/ml and 0.5 mg/ml), MCZ (100 mg/ml and 50 mg/ml), and CIC (150 mg/ml and 75 mg/ml).
(E–H) Log of CFU/ml remaining after 3 hr of drug exposure of wild-type S. cerevisiae and mutants targeting DSBR. The reported error is SD with nR 3.
(legend continued on next page)
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strains with reported phenotypes were verified by PCR. Stains PAB202
(BY4742 cit1D::kanMX4 cit3D::URA3), PAB205 (BY4742 cit3D::kanMX4
cit2D::LEU2), and PAB208 (PAB202 cit2D::LEU2) were created by direct trans-
formation of PCR products as previously described (Brachmann et al., 1998).
S. cerevisiae rad50 and rad52 knockouts were derivatives of MKP-0 and
generously provided to us by Dr. Simone Moertl (Steininger et al., 2010).
Wild-type C. albicans strain, SC5314, was used in metabolomic profiling and
HPF measurements. C. albicans DNA repair mutants used in this work were
derivatives of DKCa39, generously provided by Dr. David T. Kirkpatrick. A
complete list of DKCa strains used in this study is provided in Table S3.
SDC media and synthetic complete media with 2% acetate (pH 6.5) were
prepared as previously described (Burke et al., 2000; Wickerham, 1946).
Fungicidal Killing and Fluorescent Dye Assays
Overnight yeast cultures were diluted into the indicatedmedia and grown to an
optical density 600 of 0.2, at which point the AFs were added. CFU were
measured by plating six serial dilutions onto YPD agar plates. A more detailed
description is included in Extended Experimental Procedures.
S. cerevisiae Microarrays
Yeast cells were incubated in 25 ml SDC and grown in 250 ml flasks at 30C
and 300 rpm. AFs were added at an OD600 of 0.2. Cells were harvested after
treatment and their RNA was isolated and processed as previously described
(Schmitt et al., 1990). The complete microarray analysis procedures are
described in Extended Experimental Procedures.
Metabolomic Profiling
C. albicans cells were lysed and assayed by Metabolon as previously
described (Shakoury-Elizeh et al., 2010). ATP and AMP were extracted as
previously described (Walther et al., 2010) and analyzed by HPLC. This proce-
dure is more fully described in Extended Experimental Procedures.
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